Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 63768

9 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
November 26, 2012
Product types
Device
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Fresenius Medical Care Holdings, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

9 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 9

Fresenius GranuFlo Dry Acid Concentrate For Bicarbonate Dialysis 2.0 K 2.5 Ca 1 Mg 16.5 GAL Catalog Number: OFD2251-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0676-2013
Recall number
Z-0676-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
101,108 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Numbers: 12NXGF001, 12NXGF003, 12NXGF006, 12NXGF007, 12NXGF013,, 12NXGF015, 12NXGF016, 12NXGF017, 12PXGF001, 12PXGF003, 12PXGF005, 12PXGF007, 12PXGF009, 12PXGF012, 12PXGF013, 12PXGF015, 12PXGF016

Distribution pattern

US Nationwide Distribution

device · product 2 of 9

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 2.0K 2.0 Ca 1Mg .16.5GAL Catalog Number: OFD2201-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0677-2013
Recall number
Z-0677-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
17,782 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Numbers:12NXGF004, 12NXGF008, 12PXGF010, 12PXGF014

Distribution pattern

US Nationwide Distribution

device · product 3 of 9

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 3.0K 2.5 Ca 1Mg .16.5GAL Catalog Number: OFD3251-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0678-2013
Recall number
Z-0678-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
14,240 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Numbers:12NXGF002, 12NXGF014, 12PXGF006,

Distribution pattern

US Nationwide Distribution

device · product 4 of 9

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 2.0K 2.25 Ca 1Mg .16.5GAL Catalog Number: OFD2231-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0679-2013
Recall number
Z-0679-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
13,409 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Numbers:12NXGF005, 12NXGF019, 12PXGF008

Distribution pattern

US Nationwide Distribution

device · product 5 of 9

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 1.0K 2.0 Ca 1Mg .16.5GAL Catalog Number: OFD1201-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0680-2013
Recall number
Z-0680-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
5 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Number:12NXGF009

Distribution pattern

US Nationwide Distribution

device · product 6 of 9

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 2.0K 2,5 Ca 0.75 Mg .16.5GAL Catalog Number: OFD2225-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0681-2013
Recall number
Z-0681-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
5,689 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Numbers:12NXGF011, 12PXGF004

Distribution pattern

US Nationwide Distribution

device · product 7 of 9

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 2.0K 2,5 Ca 0.75Mg .16.5GAL Catalog Number: OFD2223-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0682-2013
Recall number
Z-0682-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
2493 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Number:12NXGF012

Distribution pattern

US Nationwide Distribution

device · product 8 of 9

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 3.0K 2,0 Ca 1.0Mg .16.5GAL Catalog Number: OFD3201-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0683-2013
Recall number
Z-0683-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
670 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Number:12PXGF017

Distribution pattern

US Nationwide Distribution

device · product 9 of 9

Fresenius GranuFlo Naturalyte Dry Acid Concentrate For Bicarbonate Dialysis 3.0K 2,5 Ca 0.75Mg .16.5GAL Catalog Number: OFD2325-3B Product Usage: GranuFlo is indicated in the treatment of acute and chronic renal failure during the hemodialysis treatment.

Z-0684-2013
Recall number
Z-0684-2013
Initiated
November 26, 2012
Classification
Class III
Status
Terminated
Quantity
2711 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
GranuFlo Dry Acid Concentrate may show discoloration

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

GranuFlo Dry Acid Concentrate may show discoloration

Code information

Lot Number:12PXGF002

Distribution pattern

US Nationwide Distribution